Richa Poddar - Dec 6, 2021 Form 3 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Chief Commercial Officer
Signature: /s/ William Cook, as Attorney in Fact for Richa Poddar
Stock symbol: AGIO
Transactions as of: Dec 6, 2021
Transactions value $: $0
Form type: 3
Date filed: 12/15/2021, 03:56 PM
Next filing: Feb 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AGIO	Common stock						150	Dec 6, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AGIO	Restricted stock units							Dec 6, 2021	Common stock	658		Direct	F1, F2
holding	AGIO	Restricted stock units							Dec 6, 2021	Common stock	3.48K		Direct	F2, F3
holding	AGIO	Restricted stock units							Dec 6, 2021	Common stock	5K		Direct	F2, F4
holding	AGIO	Restricted stock units							Dec 6, 2021	Common stock	6.2K		Direct	F2, F5
holding	AGIO	Stock options (right to buy)							Dec 6, 2021	Common stock	5.1K	$59.68	Direct	F6
holding	AGIO	Stock options (right to buy)							Dec 6, 2021	Common stock	3.65K	$50.40	Direct	F7
holding	AGIO	Stock options (right to buy)							Dec 6, 2021	Common stock	6.86K	$77.70	Direct	F8
holding	AGIO	Stock options (right to buy)							Dec 6, 2021	Common stock	7.9K	$58.86	Direct	F9
holding	AGIO	Stock options (right to buy)							Dec 6, 2021	Common stock	2.61K	$51.51	Direct	F10
holding	AGIO	Stock options (right to buy)							Dec 6, 2021	Common stock	3.1K	$56.68	Direct	F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.
F2	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3	The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.
F4	The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022.
F5	The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
F6	This option was granted on June 6, 2016. The shares underlying this option are fully vested.
F7	This option was granted on February 21, 2017. The shares underlying this option are fully vested.
F8	This option was granted on February 16, 2018. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F9	This option was granted on February 22, 2019. The shares underlying this option vest as to 25% of the underlying shares on February 22, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F10	This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F11	This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.